Company / Current Liabilities per Share
Elicio Therapeutics, Inc. Current Liabilities per Share History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.21
FY2022
5-year range
$0.21 / $0.74
FY2021-FY2022
Trend
-71.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.21 in FY2022.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities per share decreased 71.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.21 | -71.2% |
| FY2021 | $0.74 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026